We are leaving no stone unturned in this race for vaccines for Canadians.
As you can see, and as I've mentioned, we were able to accelerate 3.5 million doses from later quarters into this quarter to accelerate the pace of vaccinations for Canadians. In addition, we've moved up 17 million additional doses from Q3 to Q2 or Q1 to ensure that 36.5 million Canadians will be inoculated should they want a vaccine prior to the end of June, and then 118 million prior to the end of September, and that's just from approved suppliers alone.
We are continuing to ensure that the vaccine suppliers and other organizations such as the Serum Institute of India, as well as governments—including the United States government, with whom we negotiated successfully for 1.5 million doses of AstraZeneca arriving very shortly—are keenly aware that Canada is willing and able and aggressively looking for the acceleration of doses on a day by day or week by week basis.
That's why, Mr. Chair, I am continually in touch with our suppliers not just weekly but daily, to ensure that we have the earliest possible delivery of vaccines into this country. Despite vaccine nationalism that we are seeing throughout this world, Canada has continued to receive shipments of vaccines from Europe and from India because of the commitment we have every single day to ensure that vaccines are arriving on this country's soil, and it's a task that we will not stop at until it is accomplished.